Gyeryong, South Korea

Gil-Yong Jee

This inventor holds 1 USPTO granted patent. Top assignee: Dinona Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gil-Yong Jee. Retrieved from https://idiyas.com/inventor/gil-yong-jee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gil-Yong Jee: Innovator in MRSA Detection

Introduction

Gil-Yong Jee is a notable inventor based in Gyeryong, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the detection of methicillin-resistant Staphylococcus aureus (MRSA). His innovative work has the potential to enhance the accuracy and speed of MRSA detection, which is crucial in clinical settings.

Latest Patents

Gil-Yong Jee holds a patent for a detection method for methicillin-resistant Staphylococcus aureus. The patent describes an antibody against a protein specifically expressed in MRSA strains. This invention enables fast and accurate detection of MRSA by utilizing both a PBP2a-specific antibody for detecting PBP2a and a Protein A-specific antibody for detecting Protein A. This advancement is vital for improving patient outcomes in healthcare.

Career Highlights

Gil-Yong Jee is associated with Dinona Inc., where he continues to work on innovative solutions in the medical field. His dedication to research and development has positioned him as a key figure in the fight against antibiotic-resistant infections.

Collaborations

Some of his notable coworkers include Hae-Jung Kim and Sang-Soon Yoon. Their collaborative efforts contribute to the ongoing advancements in medical diagnostics and treatment options.

Conclusion

Gil-Yong Jee's work in developing a detection method for MRSA showcases his commitment to innovation in healthcare. His contributions are essential in addressing the challenges posed by antibiotic-resistant bacteria.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…